Predictive Oncology Ownership | Who Owns Predictive Oncology?


OverviewRevenueFinancialsChartTranscripts

Predictive Oncology Ownership Summary


Predictive Oncology is owned by 0.22% institutional investors, 4.93% insiders, and 94.86% retail investors. Vanguard group is the largest institutional shareholder, holding 2.47% of POAI shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.47% of its assets in Predictive Oncology shares.

POAI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPredictive Oncology0.22%4.93%94.86%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryMedical Instruments & Supplies Stocks35.51%13.37%51.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group17.91K2.47%$128.03K
Diametric capital, lp136.92K0.79%$221.81K
Alpine global management64.51K0.37%$104.50K
Prelude capital management52.66K0.30%$85.31K
Geode capital management46.69K0.27%$75.64K
Vanguard fiduciary trust14.13K0.08%$22.88K
Ubs group12.63K0.07%$20.46K
Tower research capital llc (trc)895.000.01%$1.45K
Carnegie mellon university691.000.00%$1.12K
Vanguard global advisers96.000.00%$156.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Diametric capital, lp136.92K0.06%$221.81K
Alpine global management64.51K0.02%$104.50K
Prelude capital management52.66K0.01%$85.31K
Carnegie mellon university691.000.00%$1.12K
Advisor group22.00-$34.00
Tower research capital llc (trc)895.00-$1.45K
Pnc financial services group---
Millennium management---
Advisornet financial---
Federation des caisses desjardins du quebec---

Top Buyers

HolderShares% AssetsChange
Diametric capital, lp136.92K0.06%136.92K
Prelude capital management52.66K0.01%52.66K
Geode capital management46.69K-22.55K
Vanguard group17.91K-17.91K
Vanguard fiduciary trust14.13K-14.13K

Top Sellers

HolderShares% AssetsChange
Alpine global management64.51K0.02%-21.50K
Millennium management---18.30K
Virtu financial---16.23K
State street---13.84K
Raymond james financial---3.87K

New Positions

HolderShares% AssetsChangeValue
Prelude capital management52.66K0.01%52.66K$85.31K
Vanguard group17.91K-17.91K$128.03K
Vanguard fiduciary trust14.13K-14.13K$22.88K
Vanguard global advisers96.00-96.00$156.00
Caitong asset management1.00-1.00$2.00

Sold Out

HolderChange
Fmr-1.00
Citigroup-1.00
Sbi securities-5.00
Pnc financial services group-16.00
Federation des caisses desjardins du quebec-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20268-42.86%38,219-74.71%-0.05%6-50.00%--100.00%
Dec 31, 2025814.29%46,423103.41%614522.61%7133.33%--100.00%
Sep 30, 20252-81.82%801-99.56%-0.01%--100.00%2100.00%
Jun 30, 202511-26.67%181,793-1.57%129.93%4-20.00%1-
Mar 31, 20252-96--59620.00%----

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr48.01K0.47%-21.88K
Fidelity Extended Market Index37.13K0.32%955.00
Spartan Extended Market Index Pool E9.87K0.14%9.14K
Spartan Extended Market Index Pool F10.48K0.09%261.00
Fidelity Series Total Market Index9.84K0.09%-
SSgA U.S. Extended Market Index Class I4.75K0.07%-
Northern Trust Extended Eq Market Idx3.50K0.04%-
NT Ext Equity Mkt Idx Fd - L3.50K0.04%-
Spartan Total Market Index Pool G4.17K0.04%1.02K
Fidelity Total Market Index3.78K0.03%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 25, 2023Nuzum Charles Lee Sr-Sell$30.39K
Dec 15, 2022HANDLEY DANIEL E-Buy$2.46K
Dec 02, 2022MYERS ROBERT L CHIEF FINANCIAL OFFICERBuy$5.00K
Dec 02, 2022Vennare Raymond F-Buy$2.38K
Dec 02, 2022Vennare Raymond F-Buy$207.40

Insider Transactions Trends


DateBuySell
2025 Q3--
2024 Q2--
2023 Q4--
2023 Q3-1
2023 Q2--

POAI Ownership FAQ


Who Owns Predictive Oncology?

Predictive Oncology shareholders are primarily institutional investors at 0.22%, followed by 4.93% insiders and 94.85% retail investors. The average institutional ownership in Predictive Oncology's industry, Medical Instruments & Supplies Stocks, is 35.51%, which Predictive Oncology falls below.

Who owns the most shares of Predictive Oncology?

Predictive Oncology’s largest shareholders are Vanguard group (17.91K shares, 2.47%), Diametric capital, lp (136.92K shares, 0.79%), and Alpine global management (64.51K shares, 0.37%). Together, they hold 3.63% of Predictive Oncology’s total shares outstanding.

Does Blackrock own Predictive Oncology?

BlackRock is not among the top 10 institutional shareholders of Predictive Oncology.

Who is Predictive Oncology’s biggest shareholder by percentage of total assets invested?

Diametric capital, lp is Predictive Oncology’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 136.92K Predictive Oncology shares, valued at 221.81K$.

Who is the top mutual fund holder of Predictive Oncology shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Predictive Oncology shares, with 0.47% of its total shares outstanding invested in 48.01K Predictive Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools